Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Loco-Regional Skin Toxicity Induced by an In Situ Forming Depot after a Single Subcutaneous Injection at Different Volumes and Flow Rates in Göttingen Minipigs.

International journal of molecular sciences·2021
Same author

Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiative.

Regulatory toxicology and pharmacology : RTP·2018
Same author

Safety profile of etifoxine: A French pharmacovigilance survey.

Fundamental & clinical pharmacology·2015
Same author

Electrophysiological, haemodynamic, and mitochondrial alterations induced by levobupivacaine during myocardial ischemia in a pig model: protection by lipid emulsions?

Fundamental & clinical pharmacology·2015
Same author

Decrease in factor V activity in patients treated with azathioprine or 6-mercaptopurine.

Clinics and research in hepatology and gastroenterology·2014
Same author

Imiquimod and pulmonary embolism: a case report.

Therapie·2014

Related Experiment Video

Updated: May 18, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Translational immunologic safety evaluation: a perspective.

Jacques Descotes1

  • 1Poison Center and Pharmacovigilance Department, Lyon University Hospitals, Lyon, France. descotes@me.com

Journal of Immunotoxicology
|September 13, 2012
PubMed
Summary

Translational immunologic safety evaluation needs more research, especially for immunostimulation and autoimmunity. Standardizing assays and biomarkers is crucial for predicting drug safety in clinical trials.

More Related Videos

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Related Experiment Videos

Last Updated: May 18, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation
09:13

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Area of Science:

  • Biomedical Sciences
  • Translational Research
  • Immunotoxicology

Background:

  • Translational research is advancing rapidly in biomedical sciences.
  • Immunologic safety evaluation, particularly concerning immunostimulation, hypersensitivity, and autoimmunity, has received limited attention.
  • Existing assays and animal models for immunotoxic hazards primarily focus on immunosuppression.

Purpose of the Study:

  • To highlight the limited attention given to translational immunologic safety evaluation.
  • To emphasize the need for standardizing and validating assays, models, and biomarkers for regulatory use.
  • To underscore the importance of immune monitoring in clinical studies for identifying unforeseen safety issues.

Main Methods:

  • Review of current knowledge and practices in translational immunologic safety.
  • Identification of existing assays and animal models for immunotoxic hazard assessment.
  • Discussion of the role of regulatory bodies and the limitations of current predictive models.

Main Results:

  • Limited focus on immunostimulation, hypersensitivity, and autoimmunity in current translational immunologic safety research.
  • Uncertainty regarding the predictive capacity of existing assays and models for drug-induced immunotoxic effects.
  • Regulatory bodies recommend some assays, but their clinical relevance remains to be fully established.

Conclusions:

  • Significant gaps exist in translational immunologic safety evaluation.
  • Standardization and validation of predictive models and biomarkers are essential.
  • Further research and immune monitoring are required to enhance drug and chemical safety.